Efficacy and safety of electrical moxibustion for knee osteoarthritis: study protocol for a randomized controlled trial

Ha-Ra Kang, Chan-Yung Jung, Seung-Deok Lee, Kyung-Ho Kim, Kap-Sung Kim, Eun-Jung Kim, Ha-Ra Kang, Chan-Yung Jung, Seung-Deok Lee, Kyung-Ho Kim, Kap-Sung Kim, Eun-Jung Kim

Abstract

Background: Knee osteoarthritis (KOA) is a significant health issue because it causes pain and functional limitation. Many studies have reported that moxibustion, a treatment in traditional Korean medicine, is effective in treating KOA. However, conventional moxibustion produces smoke, harmful gases, and odors that can adversely affect the eyes, skin, and throat. It is also difficult to control the intensity of stimulation in conventional moxibustion. An electrical moxibustion device was developed to circumvent these problems, but there are few studies of that device. We will evaluate the efficacy and safety of electrical moxibustion as a treatment for KOA, and compare it with traditional indirect moxibustion and usual care.

Methods: This is a multicenter, randomized, open, assessor-blinded, parallel-group clinical trial. A total of 138 eligible participants with KOA will be randomly allocated into three groups (electrical moxibustion, traditional indirect moxibustion, or usual care) with a 1:1:1 ratio. Participants in each moxibustion group will receive 12 sessions of moxibustion treatment at 6 acupoints (ST36, ST35, ST34, SP9, EX-LE4, SP10) plus up to 2 points of "ashi", if needed, over a period of 6 weeks (2 sessions per week). A specifically designed device that provides thermal stimulation using electrical energy will be used for the electrical moxibustion group. Participants in the usual care group will receive usual treatment and self-care. The primary outcome measure is change in pain on a numerical rating scale (NRS) from week 1 to week 6. The secondary outcome measures are pain assessed on a visual analog scale (VAS), the Korean version of the Western Ontario and McMaster osteoarthritis index (K-WOMAC), patient global assessment (PGA), and the European quality of life five dimension five level scale (EQ-5D-5 L). Safety will be assessed by monitoring adverse events at each visit. Follow-up measurements will be performed at 12 weeks after baseline measurements.

Discussion: This trial will provide evidence on the efficacy and safety of electrical moxibustion as a treatment for KOA.

Trial registration: ClinicalTrials.gov, NCT03287570 . Registered on 19 September 2017.

Keywords: Electrical moxibustion; Knee osteoarthritis; Moxibustion; Randomized controlled trial.

Conflict of interest statement

Ethics approval and consent to participate

The protocol was written according to general ethical guidelines of the Declaration of Helsinki and Korean Good Clinical Practice. The protocol was also approved by the Institutional Review Board of each trial center (protocol number 2017–0002, protocol version 3.1) and was registered at ClinicalTrials.gov. All participants will be informed of the methods of the trial, including potential benefits, possible adverse events, and personal responsibilities, and will then provide written informed consent.

Consent for publication

All authors have reviewed the final manuscript, and consent for publication. There are no personal or private data contained in this manuscript.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Procedures used for recruitment, randomization, treatment, and assessment. Participants with diagnoses of KOA will be recruited from two centers. The 2 treatment groups will receive 2 sessions per week of moxibustion for 6 weeks, followed by a 6 week follow-up period. Outcome measures will be determined at every visit
Fig. 2
Fig. 2
Schedule to be used for enrolment, intervention, and assessments. NRS, Numerical rating scale; VAS, Visual analogue scale; K-WOMAC, Korean version of Western Ontario and McMaster Universities osteoarthritis index; PGA, Patients global assessment; EQ-5D-5L, European quality of life five dimension five level scale
Fig. 3
Fig. 3
Acupoints used in the trial. The lines refer to acupoints of ‘Zusanli’ (ST36), ‘Dubi’ (ST35) and ‘Liangqiu’ (ST34) on the lateral side of the knee, and ‘Yinlingquan’ (SP9), ‘Neixiyan’ (EX-LE4), and ‘Xuehai’ (SP10) on the medial side of the knee
Fig. 4
Fig. 4
Moxibustion devices. A Electrical moxibustion device, showing the twelve heating units in the charging equipment (a), the power unit (b), and the bottom of the unit with the electrically heated board (c). B Traditional indirect moxibustion device

References

    1. Yanhong C, Xiaobing S. Current status and progress on the epidemiology of knee osteoarthritis at home and abroad. Chin J Tradit Med Traumatol Orthop. 2012;20(6):81–84.
    1. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41(8):1343–1355. doi: 10.1002/1529-0131(199808)41:8<1343::AID-ART3>;2-9.
    1. Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clin Orthop Relat Res. 2004;427(Suppl):S6–15. doi: 10.1097/01.blo.0000143938.30681.9d.
    1. Dunlop DD, Manheim LM, Yelin EH, Song J, Chang RW. The costs of arthritis. Arthritis Rheum. 2003;49(1):101–113. doi: 10.1002/art.10913.
    1. Felson DT, Lawrence RC, Hochberg MC, Mcalindon T, Dieppe PA, Minor MA, et al. Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med. 2000;133(9):726–737. doi: 10.7326/0003-4819-133-9-200011070-00015.
    1. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA. 2000;284(10):1247–1255. doi: 10.1001/jama.284.10.1247.
    1. Ezzo J, Hadhazy V, Birch S, Lao L, Kaplan G, Hochberg M, et al. Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis Rheum. 2001;44(4):819–825. doi: 10.1002/1529-0131(200104)44:4<819::AID-ANR138>;2-P.
    1. Manheimer E, Linde K, Lao L, Bouter LM, Berman BM. Meta-analysis: acupuncture for osteoarthritis of the knee. Ann Intern Med. 2007;146(12):868–877. doi: 10.7326/0003-4819-146-12-200706190-00008.
    1. Chen R, Chen M, Xiong J, Su T, Zhou M, Sun J, et al. Comparative effectiveness of the deqi sensation and non-deqi by moxibustion stimulation: a multicenter prospective cohort study in the treatment of knee osteoarthritis. Evid Based Complement Alternat Med. 2013;2013:906947.
    1. Ren X, Yao C, Wu F, Li Z, Xing J, Zhang H. Effectiveness of moxibustion treatment in quality of life in patients with knee osteoarthritis: a randomized, double-blinded, placebo-controlled trial. Evid Based Complement Altern Med. 2015;2015:569523.
    1. Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology (Oxford). 2001;40(7):779–793. doi: 10.1093/rheumatology/40.7.779.
    1. Cheng CW, Fu SF, Zhou QH, Wu TX, Schang HC, Tang XD, et al. Extending the CONSORT statement to moxibustion. J Integr Med. 2013;11(1):54–63. doi: 10.3736/jintegrmed2013009.
    1. Bensoussan A, Myers SP, Carlton AL. Risks associated with the practice of traditional Chinese medicine. Arch Fam Med. 2000;9(10):1071–1078. doi: 10.1001/archfami.9.10.1071.
    1. Zhao YY, Li WY. Effects of moxa smoke on moxibustion doctors suffering from chronic pharyngolaryngitis. Lishizhen Med Mater Med Res. 2013;24(7):1801–1802.
    1. Chang Y, Wang X, Yang H, Zhang H, Wu Q, Yu S. Small sample size epidemiological survey of the time-related exposure reaction of acupuncturists under the moxa-smoke environment. J Chengdu Univ Tradit Chin Med. 2015;38(4):6–9.
    1. Li CM. The influence of inhalation of moxa smoke on moxibustion doctors. Int J Tradit Chin Med. 1994;16(4):57–58.
    1. Park JE, Lee SS, Lee MS, Choi SM, Ernst E. Adverse events of moxibustion: a systematic review. Complement Ther Med. 2010;18(5):215–223. doi: 10.1016/j.ctim.2010.07.001.
    1. American college of rheumatology subcommittee on osteoarthritis guidelines Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000;43(9):1905–1915. doi: 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>;2-P.
    1. Kim TH, Kim KH, Kang JW, Lee M, Kang KW, Kim JE, et al. Moxibustion treatment for knee osteoarthritis: a multi-centre, non-blinded, randomised controlled trial on the effectiveness and safety of the moxibustion treatment versus usual care in knee osteoarthritis patients. PLoS One. 2014;9(7):e101973. doi: 10.1371/journal.pone.0101973.
    1. Zhao L, Cheng K, Wang L, Wu F, Deng H, Tan M, et al. Effectiveness of moxibustion treatment as adjunctive therapy in osteoarthritis of the knee: a randomized, double-blinded, placebo-controlled clinical trial. Arthritis Res Ther. 2014;16(3):R133. doi: 10.1186/ar4590.
    1. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149–158. doi: 10.1016/S0304-3959(01)00349-9.
    1. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16(1):87–101. doi: 10.1016/0304-3959(83)90088-X.
    1. Bellamy N. Validation study of WOMAC: a health status instrument for measuring clinically-important patient-relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheumatol. 1988;1:95–108.
    1. Bae SC, Lee HS, Yun HR, Kim TH, Yoo DH, Kim SY. Cross-cultural adaptation and validation of Korean western Ontario and McMaster universities (WOMAC) and Lequesne osteoarthritis indices for clinical research. Osteoarthr Cartil. 2001;9(8):746–750. doi: 10.1053/joca.2001.0471.
    1. Rothman M, Vallow S, Damaraju CV, Hewitt DJ. Using the patient global assessment of the method of pain control to assess new analgesic modalities in clinical trials. Curr Med Res Opin. 2009;25(6):1433–1443. doi: 10.1185/03007990902862032.
    1. Armaganjian L, Staico R, Moraes A, Abizaid A, Moreira D, Amodeo C, et al. Renal sympathetic denervation and quality of life. Rev Bras Cardiol Invasiva. 2013;21(1):13–17.
    1. Kwon OS, Kim JE, Lee JW, Seo CW, Han HY, Hong SH. Analytic study of diagnostic validity by the measure of cold-heat & deficiency-excess for oriental medical examination. J Physiol Pathol Korean Med. 2009;23(1):180–185.
    1. The Korean orthopaedic association . Orthopaedics. 6. Seoul: Choisin Publishing INC; 2006. pp. 253–261.
    1. Dieppe PA. Relationship between symptoms and structural change in osteoarthritis: what are the important targets for therapy? J Rheumatol. 2005;32(6):1147–1149.
    1. Yoon JH. Osteoarthritis update. Korean J Med. 2012;82(2):170–174. doi: 10.3904/kjm.2012.82.2.170.
    1. Sandner-Kiesling A, Litscher G, Voit-Augustin H, James RL, Schwarz G. Laser doppler flowmetry in combined needle acupuncture and moxibustion: a pilot study in healthy adults. Lasers Med Sci. 2001;16(3):184–191. doi: 10.1007/PL00011353.
    1. Woo HS, Lee YH, Kim CC. The review and study trend of moxibustion. The Acupunct. 2002;19(4):1–15.
    1. Cho ZH, Hwang SC, Wong EK, Son YD, Kang CK, Park TS, et al. Neural substrates, experimental evidences and functional hypothesis of acupuncture mechanisms. Acta Neurol Scand. 2006;113(6):370–377. doi: 10.1111/j.1600-0404.2006.00600.x.
    1. Chiba A, Nakanishi H, Chichibu S. Thermal and antiradical properties of indirect moxibustion. Am J Chin Med. 1997;25(3–4):281–287. doi: 10.1142/S0192415X97000317.
    1. Yamashita H, Ichiman Y, Tanno Y. Changes in peripheral lymphocyte subpopulation after direct moxibustion. Am J Chin Med. 2001;29(2):227–235. doi: 10.1142/S0192415X01000265.
    1. Kim TJ, Lee YJ, Kim YI, Eom IK, Chae H, Hwangbo M, et al. Development of programmable and rechargeable moxibustion device. The Acupunct. 2011;28(2):49–55.
    1. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20(8):637–648. doi: 10.1016/0021-9681(67)90041-0.
    1. Macpherson H. Pragmatic clinical trials. Complement Ther Med. 2004;12(2–3):136–140. doi: 10.1016/j.ctim.2004.07.043.
    1. Kim SW, Hong SJ, Park SH, Jung CY, Yoon EH, Lee SD. Some results from a sample survey on the use of moxibustion therapeutics in Korea. The Acupunct. 2010;27(2):115–121.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever